What Side of the Stem Cell “Fence” are you on?
Imagine running a company in the small cap space and experiencing all the hardships that go along with it. Things like complying with Sarbanes Oxley on a limited budget, constantly lobbying investors for more money and fulfilling your fiduciary duty to the shareholders. Toss in a worldwide debate over your business practice and U.S. government restrictions on federal funding and you’d be the CEO of a small-cap company focused on stem cell research. Sound like a dream job? More like being one of the Spartans from “300” fighting an overwhelming force of a million Persians. This is an everyday reality…